documents: FDA-2009-P-0597-0017

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2009-P-0597-0017 FDA FDA-2009-P-0597 Tab 30/Exhibit 30 - "FDA/CDER Response to Alza Corporation, January 28, 2005, re Docket IDs 2004P-0506/CP1, 2004P-0472/CP1,2004P-0540/CP1, and 2004P-340/CP1" - [GlaxoSmithKline (Ropes & Gray LLP) - Citizen Petition] Supporting & Related Material CP-Citizen Petition (Supporting & Related Materials) 2009-12-29T05:00:00Z 2009 12     2009-12-30T00:43:00Z   0 0 0900006480a6caf4

Links from other tables